|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01246 BOILLHEALTHCARE
Nominal 
0.021 0.000 (0.000%) | 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Turnover | 76,920 | -73.030% | 285,204 | 348,271 | 1,016,162 | 216,710 |
| Cost of Sales | (83,919) | -69.322% | (273,549) | (348,161) | (907,740) | (197,739) |
| Gross Profit | (6,999) | -- | 11,655 | 110 | 108,422 | 18,971 |
| 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (748,512) | 1163.631% | (59,235) | (152,566) | (631,164) | 566 | |
| Change in FV & Impairment on Others | (522) | 1350.000% | (36) | 319 | (1,850) | (1,074) | |
| Profit / (Loss) on Disposal | -- | -- | 17,755 | -- | -- | -- | |
| Other Non-operating Items | (27,784) | -84.616% | (180,599) | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (17,721) | (940) | |
| Profit / (Loss) before Taxation | (873,527) | 217.067% | (275,502) | (224,636) | (744,781) | (180,629) | |
| Taxation | 581 | -- | (7,625) | (1,998) | (10,954) | 5,139 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | (300,941) | -- | -- | |
| Non-controlling Interests | 42,981 | -73.870% | 164,487 | 99,320 | 237,937 | 33,004 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (829,965) | 599.566% | (118,640) | (428,255) | (517,798) | (142,486) | |
| 2025/03 - Final HKD(K$) | %Chg (Compare to Final) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Finance Costs / (Income) | 66,222 | 204.749% | 21,730 | 43,424 | 121,631 | 119,909 |
| Depreciation & Amortisation | 2 | -99.749% | 796 | 949 | 22,352 | 19,738 |
| Directors' Emoluments | -- | -- | -- | 2,183 | 1,100 | 1,100 |
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | Disclaimer | -- | Disclaimer | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2025/03 - Final | %Chg (Compare to Final) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | -61.120 | 599.314% | -8.740 | -31.540 | -38.130 | -12.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 0.050 | (0.084) | (0.137) |
| NBV per share ($) | (0.849) | -- | (0.245) | (0.100) | (0.008) | 0.343 |
| Remarks: | Real time quote last updated: 16/02/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -35,509 |
| %Change | 31.651% |
| EPS / (LPS) | HKD -0.026 |
| NBV Per Share ($) | HKD -0.889 |